Julia Madsen - Jun 2, 2021 Form 4 Insider Report for STERIS plc (STE)

Role
Senior VP, Life Sciences
Signature
/s/ Ronald E. Snyder, Authorized Representative under Power of Attorney
Stock symbol
STE
Transactions as of
Jun 2, 2021
Transactions value $
$0
Form type
4
Date filed
6/3/2021, 04:44 PM
Previous filing
Jun 2, 2021
Next filing
Oct 5, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STE Ordinary Shares Award $0 +1.44K +32.6% $0.00 5.86K Jun 2, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STE Employee Stock Option (right to buy) Options Exercise $0 +7.6K $0.00 7.6K Jun 2, 2021 Ordinary Shares 7.6K $210.30 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All 1,440 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 360 on June 2, 2022; 360 on June 2, 2023; 360 on June 3, 2024 and 360 on June 2, 2025.
F2 3,510 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 349 on October 1, 2021; 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 360 on June 2, 2022; 349 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 360 June 2, 2023; 349 on October 2, 2023; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024 and 360 on June 2, 2025.
F3 This option becomes exercisable as follows: 1,901 on June 2, 2022; 1,901 on June 2, 2023; 1,901 on June 3, 2024 and 1,901 on June 2, 2025.